CareDx EBITDA 2013-2025 | CDNA
CareDx ebitda from 2013 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| CareDx Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $61 |
| 2023 | $-188 |
| 2022 | $-61 |
| 2021 | $-17 |
| 2020 | $-13 |
| 2019 | $-17 |
| 2018 | $-9 |
| 2017 | $-13 |
| 2016 | $-30 |
| 2015 | $-11 |
| 2014 | $2 |
| 2013 | $0 |
| 2012 | $-1 |
| CareDx Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-8 |
| 2024-12-31 | $82 |
| 2024-09-30 | $-5 |
| 2024-06-30 | $0 |
| 2024-03-31 | $-16 |
| 2023-12-31 | $-119 |
| 2023-09-30 | $-25 |
| 2023-06-30 | $-24 |
| 2023-03-31 | $-20 |
| 2022-12-31 | $-15 |
| 2022-09-30 | $-13 |
| 2022-06-30 | $-18 |
| 2022-03-31 | $-15 |
| 2021-12-31 | $-12 |
| 2021-09-30 | $-5 |
| 2021-06-30 | $-1 |
| 2021-03-31 | $2 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-4 |
| 2019-12-31 | $-3 |
| 2019-09-30 | $-4 |
| 2019-06-30 | $-6 |
| 2019-03-31 | $-4 |
| 2018-12-31 | $-1 |
| 2018-09-30 | $-2 |
| 2018-06-30 | $-4 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-3 |
| 2017-09-30 | $-4 |
| 2017-06-30 | $1 |
| 2017-03-31 | $-7 |
| 2016-12-31 | $-17 |
| 2016-09-30 | $-2 |
| 2016-06-30 | $-5 |
| 2016-03-31 | $-6 |
| 2015-12-31 | $-4 |
| 2015-09-30 | $-3 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $-1 |
| 2014-12-31 | $0 |
| 2014-09-30 | $2 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $1 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.951B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.426B | 25.40 |
| Elevance Health (ELV) | United States | $85.189B | 10.99 |
| CVS Health (CVS) | United States | $80.455B | 10.00 |
| Cencora (COR) | United States | $56.610B | 19.69 |
| DiDi Global (DIDIY) | China | $22.073B | 33.50 |
| Natera (NTRA) | United States | $21.942B | 0.00 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.094B | 0.00 |
| Solventum (SOLV) | United States | $12.651B | 13.39 |
| CochLear (CHEOY) | Australia | $11.541B | 0.00 |
| Revvity (RVTY) | United States | $10.528B | 18.12 |
| ICON (ICLR) | Ireland | $10.410B | 9.68 |
| Viatris (VTRS) | United States | $10.199B | 3.50 |
| Doximity (DOCS) | United States | $9.673B | 44.78 |
| HealthEquity (HQY) | United States | $8.893B | 43.75 |
| Avantor (AVTR) | United States | $8.831B | 12.83 |
| Medpace Holdings (MEDP) | United States | $8.560B | 22.73 |
| Sonic Healthcare (SKHHY) | Australia | $8.409B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.633B | 13.00 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.170B | 38.60 |
| Bausch + Lomb (BLCO) | Canada | $4.047B | 23.85 |
| Sotera Health (SHC) | United States | $3.460B | 19.66 |
| Alignment Healthcare (ALHC) | United States | $3.069B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.998B | 38.98 |
| Concentras Parent (CON) | United States | $2.754B | 15.92 |
| Organon (OGN) | United States | $2.405B | 2.56 |
| GeneDx Holdings (WGS) | United States | $2.115B | 81.46 |
| Ardent Health Partners (ARDT) | United States | $2.061B | 8.79 |
| Premier (PINC) | United States | $1.882B | 14.29 |
| Progyny (PGNY) | United States | $1.860B | 40.94 |
| PACS (PACS) | United States | $1.495B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.364B | 27.29 |
| Teladoc Health (TDOC) | United States | $1.205B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.163B | 8.85 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.982B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.935B | 14.13 |
| Agilon Health (AGL) | United States | $0.931B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.777B | 7.28 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.611B | 4.11 |
| LifeMD (LFMD) | United States | $0.584B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.528B | 0.00 |
| Enhabit (EHAB) | United States | $0.525B | 43.21 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| Sonida Senior Living (SNDA) | United States | $0.457B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.290B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.247B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.128B | 0.00 |
| So-Young (SY) | China | $0.092B | 0.00 |
| OncoCyte (OCX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.041B | 0.00 |
| ModivCare (MODV) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |